Published in Biopharm Drug Dispos on September 17, 2013
A Six-Stage Workflow for Robust Application of Systems Pharmacology. CPT Pharmacometrics Syst Pharmacol (2016) 0.77
Network reconstruction based on proteomic data and prior knowledge of protein connectivity using graph theory. PLoS One (2015) 0.77
Causal protein-signaling networks derived from multiparameter single-cell data. Science (2005) 34.28
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature (2012) 31.78
ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics (2006) 14.49
Metabolic stability and epigenesis in randomly constructed genetic nets. J Theor Biol (1969) 13.14
COPASI--a COmplex PAthway SImulator. Bioinformatics (2006) 10.57
Drug target identification using side-effect similarity. Science (2008) 9.24
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat Biotechnol (2007) 6.56
How to infer gene networks from expression profiles. Mol Syst Biol (2007) 5.79
What is principal component analysis? Nat Biotechnol (2008) 5.28
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat Biotechnol (2011) 4.83
Structural and functional analysis of cellular networks with CellNetAnalyzer. BMC Syst Biol (2007) 4.52
The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer (2007) 4.40
Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci U S A (2010) 4.35
Physicochemical modelling of cell signalling pathways. Nat Cell Biol (2006) 4.34
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res (2012) 4.34
Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol (2011) 3.65
Circumventing cancer drug resistance in the era of personalized medicine. Cancer Discov (2012) 3.25
Untangling the wires: a strategy to trace functional interactions in signaling and gene networks. Proc Natl Acad Sci U S A (2002) 3.18
Model-based drug development. Clin Pharmacol Ther (2007) 3.04
Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction. Mol Syst Biol (2009) 2.98
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome. J Natl Cancer Inst (2012) 2.79
A chemical and phosphoproteomic characterization of dasatinib action in lung cancer. Nat Chem Biol (2010) 2.53
A systems approach to prion disease. Mol Syst Biol (2009) 2.49
Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat Biotechnol (2002) 2.43
A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis. Arthritis Rheum (2007) 2.36
Physiologically-based pharmacokinetics in drug development and regulatory science. Annu Rev Pharmacol Toxicol (2011) 2.18
Identifying drug effects via pathway alterations using an integer linear programming optimization formulation on phosphoproteomic data. PLoS Comput Biol (2009) 1.80
Networks inferred from biochemical data reveal profound differences in toll-like receptor and inflammatory signaling between normal and transformed hepatocytes. Mol Cell Proteomics (2010) 1.77
Novel computational approaches to polypharmacology as a means to define responses to individual drugs. Annu Rev Pharmacol Toxicol (2011) 1.76
Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis. Annu Rev Pharmacol Toxicol (2007) 1.70
Emergent decision-making in biological signal transduction networks. Proc Natl Acad Sci U S A (2008) 1.69
Systems pharmacology: bridging systems biology and pharmacokinetics-pharmacodynamics (PKPD) in drug discovery and development. Pharm Res (2011) 1.69
Fuzzy logic analysis of kinase pathway crosstalk in TNF/EGF/insulin-induced signaling. PLoS Comput Biol (2009) 1.69
Cue-signal-response analysis of TNF-induced apoptosis by partial least squares regression of dynamic multivariate data. J Comput Biol (2004) 1.61
CellNOptR: a flexible toolkit to train protein signaling networks to data using multiple logic formalisms. BMC Syst Biol (2012) 1.60
Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis. Cancer Res (2010) 1.59
Modeling systems-level regulation of host immune responses. PLoS Comput Biol (2007) 1.56
Training signaling pathway maps to biochemical data with constrained fuzzy logic: quantitative analysis of liver cell responses to inflammatory stimuli. PLoS Comput Biol (2011) 1.53
Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research. Trends Pharmacol Sci (2008) 1.50
Mathematical modelling of cell-fate decision in response to death receptor engagement. PLoS Comput Biol (2010) 1.49
Computational approaches for analyzing information flow in biological networks. Sci Signal (2012) 1.49
Fifth-generation model for corticosteroid pharmacodynamics: application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats. J Pharmacokinet Pharmacodyn (2002) 1.40
Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics (2003) 1.40
Reverse engineering gene regulatory networks. Nat Biotechnol (2005) 1.36
Identifying mechanism-of-action targets for drugs and probes. Proc Natl Acad Sci U S A (2012) 1.36
Dissecting protein function and signaling using protein microarrays. Curr Opin Chem Biol (2009) 1.34
A review of causal inference for biomedical informatics. J Biomed Inform (2011) 1.25
Sensitivity analysis of intracellular signaling pathway kinetics predicts targets for stem cell fate control. PLoS Comput Biol (2007) 1.22
Biochemical network-based drug-target prediction. Curr Opin Biotechnol (2010) 1.15
Causal reasoning identifies mechanisms of sensitivity for a novel AKT kinase inhibitor, GSK690693. BMC Genomics (2010) 1.14
Dissecting variability in responses to cancer chemotherapy through systems pharmacology. Clin Pharmacol Ther (2010) 1.11
Cytokine-associated drug toxicity in human hepatocytes is associated with signaling network dysregulation. Mol Biosyst (2010) 1.04
Systems pharmacology for drug discovery and development: paradigm shift or flash in the pan? Clin Pharmacol Ther (2013) 1.03
Protein microarrays for personalized medicine. Clin Chem (2010) 1.03
Protein microarrays: novel developments and applications. Pharm Res (2010) 1.00
Construction of large signaling pathways using an adaptive perturbation approach with phosphoproteomic data. Mol Biosyst (2012) 0.99
Exploiting PubChem for Virtual Screening. Expert Opin Drug Discov (2010) 0.94
Metabolic network modeling and simulation for drug targeting and discovery. Biotechnol J (2011) 0.91
Combined logical and data-driven models for linking signalling pathways to cellular response. BMC Syst Biol (2011) 0.91
Drug effects viewed from a signal transduction network perspective. J Med Chem (2009) 0.87
Deciphering signaling pathways in clinical tissues for personalized medicine using protein microarrays. J Cell Physiol (2010) 0.86
Towards a rigorous assessment of systems biology models: the DREAM3 challenges. PLoS One (2010) 4.94
Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction. Mol Syst Biol (2009) 2.98
Determination of the Poisson's ratio of the cell: recovery properties of chondrocytes after release from complete micropipette aspiration. J Biomech (2005) 2.29
The logic of EGFR/ErbB signaling: theoretical properties and analysis of high-throughput data. PLoS Comput Biol (2009) 1.88
Crowdsourcing network inference: the DREAM predictive signaling network challenge. Sci Signal (2011) 1.83
Identifying drug effects via pathway alterations using an integer linear programming optimization formulation on phosphoproteomic data. PLoS Comput Biol (2009) 1.80
The pericellular matrix as a transducer of biomechanical and biochemical signals in articular cartilage. Ann N Y Acad Sci (2006) 1.71
Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity. Toxicol Appl Pharmacol (2009) 1.49
Flexible informatics for linking experimental data to mathematical models via DataRail. Bioinformatics (2008) 1.45
Comparing signaling networks between normal and transformed hepatocytes using discrete logical models. Cancer Res (2011) 1.45
Verification of systems biology research in the age of collaborative competition. Nat Biotechnol (2011) 1.28
Zonal uniformity in mechanical properties of the chondrocyte pericellular matrix: micropipette aspiration of canine chondrons isolated by cartilage homogenization. Ann Biomed Eng (2005) 1.19
Cytokine-associated drug toxicity in human hepatocytes is associated with signaling network dysregulation. Mol Biosyst (2010) 1.04
Detecting and removing inconsistencies between experimental data and signaling network topologies using integer linear programming on interaction graphs. PLoS Comput Biol (2013) 1.01
Large-scale network models of IL-1 and IL-6 signalling and their hepatocellular specification. Mol Biosyst (2011) 0.99
Construction of large signaling pathways using an adaptive perturbation approach with phosphoproteomic data. Mol Biosyst (2012) 0.99
Combined logical and data-driven models for linking signalling pathways to cellular response. BMC Syst Biol (2011) 0.91
IL-1beta decreases the elastic modulus of human tenocytes. J Appl Physiol (1985) (2006) 0.90
A multipathway phosphoproteomic signaling network model of idiosyncratic drug- and inflammatory cytokine-induced toxicity in human hepatocytes. Conf Proc IEEE Eng Med Biol Soc (2009) 0.85
Non Linear Programming (NLP) formulation for quantitative modeling of protein signal transduction pathways. PLoS One (2012) 0.82
Setting the standards for signal transduction research. Sci Signal (2011) 0.82
Glucose partition coefficient and diffusivity in the lower skin layers. Pharm Res (2006) 0.81
Identification of drug-specific pathways based on gene expression data: application to drug induced lung injury. Integr Biol (Camb) (2015) 0.80
Modeling signaling pathways in articular cartilage. Conf Proc IEEE Eng Med Biol Soc (2011) 0.75